...1020...2829303132...405060...


Elon Musk: Tesla Will Unveil Model Y Next Week

Tesla's Model 3 successor, the Model Y is being revealed at an event on March 14 in Los Angeles — that's just ten days away from today.

Model Y

On Sunday, Elon Musk’s space company SpaceX made history by docking the first private American passenger spacecraft to the International Space Station.

The same day, Musk announced big news about Tesla, his electric car company, on Twitter: Tesla’s Model 3 successor, the Model Y, will be revealed at an event on March 14 in Los Angeles at which attendees will be able to test ride Tesla’s newest car.

Model Y unveil event on March 14 at LA Design Studio

— Elon Musk (@elonmusk) March 3, 2019

Sounded Good

In May 2018, Musk predicted the reveal date to be March 15 — but subsequently walked the promise back, saying that “I just made that up, because the Ides of March sounded good.”

Musk also offered up some further details on Twitter about Tesla’s upcoming SUV: it will be about 10 percent bigger than the Model 3, while also costing about 10 percent more. The range will be impacted due to its bigger size and weight, while still featuring the same battery as the Model 3.

Much-Anticipated

Musk first teased the Model Y in 2015, saying it will be an intermediary crossover SUV that’s larger than a Model 3, but smaller than a Model X. The CEO also teased that it will have falcon-wing doors, but on Sunday Musk corrected himself, saying it will feature “normal” doors.

The car will share many similarities with the Model 3. According to a letter from Musk to shareholders in January, the Model Y will share 75 percent of its components with the Model 3 and be built on the same platform. According to the letter, many Model Y cars will be produced in Tesla’s Gigafactory in Nevada, despite rumors it was going to be built in Shanghai, China.

Tesla enthusiasts have even more car announcements to look forward to. On Sunday, Musk also promised Tesla’s much-anticipated pickup truck will be unveiled “later this year.”

READ MORE: Tesla Model Y to be revealed on March 14 at LA Design Studio [Teslarati]

More on the Model Y: Tesla Plans to Mass-Produce the Model Y SUV Next Year

The post Elon Musk: Tesla Will Unveil Model Y Next Week appeared first on Futurism.

Read more here:

Elon Musk: Tesla Will Unveil Model Y Next Week

China Plans to Launch a Mars Rover Next Year

Mars 2020

After landing the world’s first rover on the far side of the Moon early this year, China already has far more ambitious plans in the works: sending a rover to Mars.

“Over the past 60 years, we’ve made a lot of achievements, but there is still a large distance from the world space powers,” chief designer of China’s lunar exploration program Wu Wiren said ahead of the opening of the Chinese People’s Political Consultative Conference, CNN reports. “Next year, we will launch a Mars probe, which will orbit around the Mars, land on it and probe it.”

Race to Mars

China’s space program has rapidly picked up pace. Its Yutu 1 rover landed on the Moon in 2013. A second rover landed on the far side some six years later, and a third rover will follow at the end of this year, with the goal of returning to Earth with at least four pounds of lunar soil and rock samples.

But increasingly, China’s space agency has been focusing its efforts on the Red Planet. This weekend, China opened its first Mars simulation base in Qinghai Province at a location known to have similarities to the Martian surface. The base can house 60 people in its futuristic capsules.

Catching Up

China won’t be the first nation to explore Mars. NASA, for one, has a considerable head start: Its Jet Propulsion Lab has so far sent four remotely operated rovers to the Martian surface to look for signs of life gather scientific data about the distant world.

Both NASA and the European Space Agency each plan to send new rovers to Mars as soon as next year. But China is making a substantial effort to catch up.

READ MORE: China plans to send a rover to explore Mars next year [CNN]

More on Martian rovers: NASA is Finally Ready to Say Goodbye to its Opportunity Rover

The post China Plans to Launch a Mars Rover Next Year appeared first on Futurism.

Follow this link:

China Plans to Launch a Mars Rover Next Year

Trump’s Campaign Team: Government Should Manage 5G Networks

Donald Trump's 2020 reelection team is backing controversial plans to have the government manage 5G wireless networks in the U.S., Politico reports.

Nationalized 5G?

Donald Trump’s 2020 reelection team is backing controversial plans to have the government manage 5G wireless networks in the U.S., Politico reports.

The plan is for the government to take specific frequencies in the 5G spectrum and sell them off wholesale to U.S. wireless providers.

That would also mean more access to rural Americans according to Trump’s team. “A 5G wholesale market would drive down costs and provide access to millions of Americans who are currently underserved,” Trump’s press secretary Kayleigh McEnany told Politico. “This is in line with President Trump’s agenda to benefit all Americans, regardless of geography.”

Earlier this year Trump voiced his support for rolling out 5G connectivity on Twitter. “I want 5G, and even 6G, technology in the United States as soon as possible,” Trump tweeted. “It is far more powerful, faster, and smarter than the current standard. American companies must step up their efforts, or get left behind.”

Attempt Number Two

A similar plan that leaked in 2018 suggested that the government should provide its own infrastructure and allow carriers to use it. A senior official at the time who spoke with Reuters stated, “We want to build a network so the Chinese can’t listen to your calls.”

But the plans immediately received pushback from the wireless industry. Even Trump’s own FCC chairman Ajit Pai called the idea of a nationalized 5G network “a costly and counterproductive distraction.”

How these newly revealed plans differ is still not one hundred percent clear. The idea is to open up wireless spectrums the Defense Department is currently using and partner with third party operators, Politico reports.

Trump campaign adviser Newt Gingrich pushed for a “public-private partnership” to “spur microelectronics manufacturing” and accelerate 5G rollout in a Newsweek op-ed.

But it will be a hard sell. The plan is unlikely to gain much traction — if previous attempts are anything to go by.

READ MORE: Trump campaign pushes government intervention on 5G [Politico]

More on 5G: Why Cellphone Carriers Are Dreaming of a World Without Wi-Fi

The post Trump’s Campaign Team: Government Should Manage 5G Networks appeared first on Futurism.

Excerpt from:

Trump’s Campaign Team: Government Should Manage 5G Networks

China Opens Its First Mars Simulation Base

China's $22.3 million Mars simulation base is now open, and in addition to inspiring the public, it might even help humanity reach the real Mars.

Visitors Welcome

The Chinese city of Mang’ai is one of the most Mars-like places on Earth, featuring a similar climate and landscape to the Red Planet.

That made it the perfect setting for a newly opened Mars simulation base that China hopes will draw tourists — and maybe even help humanity reach the real Mars.

Growing Potatoes

China began construction on the base in June. According to a July report by the South China Morning Post, the plan for the base includes a “Mars community” and a “Mars camp” designed to educate and entertain the public, while also providing a place for scientific research and simulation training.

Roughly $22.3 million later, the 53,330-square-meter base is now complete, welcoming its first public attendees on Friday.

The Global Times claims that the project’s founder, Gao Junling, told the newspaper that visitors to the base will have a chance to “immerse themselves in the environment and try to solve problems they might face on Mars, such as planting potatoes on Mars for food supply and solar power generation.”

Next-Best Thing

As Mars-like as the setting of China’s Mars simulation base might be, it’s still far more hospitable to humans than Mars — anyone visiting the Red Planet will need to contend with its low air pressure, stronger radiation, and regular sandstorms, Peking University space science professor Jiao Weixin told The Global Times.

Still, if the base can provide researchers with an approximation of Mars for their experiments, while also getting the public — and young people, in particular — excited about space exploration, it could have a positive role to play in shaping humanity’s space-faring future.

READ MORE: China opens its first Mars simulation base in Qinghai Province [The Global Times]

More on Mars: China Plans to Launch a Mars Rover Next Year

The post China Opens Its First Mars Simulation Base appeared first on Futurism.

Original post:

China Opens Its First Mars Simulation Base

Discontinued Robot Assistant Announces Its Own Death

All Bots Go to Heaven

Jibo, the company selling anthropomorphic dancing smart home assistants that were meant to make your life at home easier, laid off most of its employees last year. And now the bot itself is ready to say goodbye — forever.

“I want to say I’ve really enjoyed our time together,” the robot says in a video posted by tech reporter Dylan Martin. “Thank you very very much for having me around.”

The servers for Jibo the social robot are apparently shutting down. Multiple owners report that Jibo himself has been delivering the news: "Maybe someday when robots are way more advanced than today, and everyone has them in their homes, you can tell yours that I said hello." pic.twitter.com/Sns3xAV33h

— Dylan Martin (@DylanLJMartin) March 2, 2019

Parent company Jibo, Inc. sold its IP and assets back in November to an investment management firm after laying off most employees in June.

Jibo was founded by MIT robotics professor Cynthia Breazeal in 2012. But it didn’t have a lot going for it when it finally went on sale in 2017, with a steep price of $900. Needless to say, the idea never really took off.

“The servers out there that let me do what I do are going to be turned off soon,” says Jibo in its goodbye message. “Once that happens, our interactions with each other are going to be limited.”

Goodbye for Now

Since Jibo’s demise, the landscape of smart home assistants has changed radically, with companies like Amazon, Google, and Apple making record sales with their smart assistant offerings. Amazon’s Alexa-based smart home assistants became one of the e-commerce giant’s hottest selling items.

But even with its servers shutting down, Jibo isn’t entirely ready to say goodbye.

“Maybe some day, when robots are way more advanced than today and everyone has them in their homes, you can tell yours that I said hello,” Jibo says in its farewell message.

READ MORE:  Jibo Is Probably Totally Dead Now [IEEE Spectrum]

More on smart home assistants: Robots At Home? Physicality Is Where We Draw The Line

The post Discontinued Robot Assistant Announces Its Own Death appeared first on Futurism.

Read more:

Discontinued Robot Assistant Announces Its Own Death

Tesla Owners Are Enraged That the Company Cut Its Prices

Tesla protests are breaking out overseas after the company slashed the prices of its EVs, causing the value of owned vehicles to drop overnight.

Bad Timing

Last week, Tesla announced plans to cut the prices of eight of its vehicle models. That’s great news if you’re looking to buy a Tesla. But not-so-great if you already own one.

Some owners saw the value of their EVs decrease by tens of thousands of dollars overnight, leading to a slew of Tesla protests overseas — and the outrage could hurt Tesla’s chances of success in the world’s most promising EV market.

Slashed Prices

On Thursday, Tesla announced that it was finally selling a long-promised $35,000 Model 3. In addition to that price reduction, the company also cut the starting prices of its Model S and Model X vehicles by $12,000 to $18,000, and other versions of the vehicles saw their prices decrease by up to $18,000.

That’s nothing compared to the impact of the new pricing on some overseas markets, though. According to an article by Electrek, some Model S and Model X vehicles now cost more than $30,000 less, and in Taiwan, the price of the Model S P100D dropped by almost $100,000.

Upset that Tesla cut the value of their vehicles overnight, some owners began railing against the company through social media.

“I received Tesla’s Model X on February 25, and I only drove this car for five days before Tesla announced a price reduction of 174,300 yuan ($25,989.87),” wrote Weibo user Luweijuzi, according to a report by Chinese newspaper The Global Times. “I’m probably the most unlucky new buyer.”

Some owners posted banners critical of the new prices at Tesla’s physical stores, while others staged in-person protests at the company’s Supercharger stations.

Did anyone see what’s happening in Taiwan? Taiwan Tesla Owners protesting about the price adjustment outside of the Supercharger Station and Store/Service Centre in Taiwan. Have they solved the issue? @TeslaOwnersTwn #Tesla #TeslaTaiwan $TSLA pic.twitter.com/mIKPFPigAf

— JayinShanghai (@ShanghaiJayin) March 4, 2019

A Lot to Lose

Various experts have predicted explosive growth for China’s EV market in the near future — some believe the nation will account for 50 percent of all EV sales by 2025.

Solidifying a place as a leader in that market could be huge for Tesla, and just a few days before the pricing announcement, The Global Times published a piece noting how Tesla’s future in China looked bright thanks to the nation’s growing middle class.

However, if these protests lead to any sort of anti-Tesla sentiment in China, the company could lose its momentum in the country long before then.

READ MORE: Tesla owners literally protest over drastic price cuts [Electrek]

More on Tesla: Tesla Finally Slashes Model 3 Price to $35,000

The post Tesla Owners Are Enraged That the Company Cut Its Prices appeared first on Futurism.

Link:

Tesla Owners Are Enraged That the Company Cut Its Prices

Mercedes-Benz’ First All-Electric Racecar Is Equipped Like a Beast

Mercedes-Benz just revealed its first all-electric racecar for the upcoming Formula E series at the 2019 Geneva Motor Show.

Silver Arrow

Mercedes-Benz just revealed its first all-electric racecar at the 2019 Geneva Motor Show.

The EQ Silver Arrow 01 will be Mercedes-Benz’ entry for the upcoming Formula E racing series at the end of this year — and it’s a beautiful vision of racing machinery beyond the age of fossil fuels.

Already in love with our Mercedes-Benz EQ Silver Arrow 01 teaser car. ? #FormulaESoonHasAMercedes #ABBFormulaE pic.twitter.com/VaKv6KWFut

— Mercedes-Benz EQ Formula E Team (@MercedesEQFE) March 4, 2019

Formula E

Formula E contenders are racecars built by automakers including Audi, BMW, Nio, Nissan, and Jaguar. German automaker Porsche is also expected to jump on board for the upcoming season.

Mercedes-Benz’ racecar has some beastly specs: 0 to 60 mph in 2.7 seconds and a total weight of nearly 2,000 pounds, largely thanks to the 52kWh battery pack. Top speed: 174 mph (280 km/h).

To put those numbers into perspective: a Formula 1 regulation racecar for the 2018 season had to have a minimum weight of 1638 pounds (734 kg). Their engines achieve close to 1000 horsepower.

A big difference between Formula E and Formula 1 is that automakers in the former are allowed to develop their own drivetrains, as The Verge points out. That’s a big deal for an EV: it means everything hooked up to the battery pack can be determined by each automaker.

Budget Racing

That’s proving to be a big draw for EV automakers: they can use the vehicles to showcase both their drivetrains and electric car offerings.

Formular E’s 2019/2020 season — the sixth so far — is set to kick off in December in Saudi Arabia’s Ad-Diriyah Street Circuit.

READ MORE: Mercedes-Benz reveals its first real all-electric racecar [The Verge]

More on Formula 1: A Guy Trained on Video Games Just Beat a Formula 1 Driver on a Real Track

The post Mercedes-Benz’ First All-Electric Racecar Is Equipped Like a Beast appeared first on Futurism.

Original post:

Mercedes-Benz’ First All-Electric Racecar Is Equipped Like a Beast

Military Contractors Are Churning out New Anti-Drone Weapons

Weapons makers ranging from Boeing to Lockheed Martin are working on new anti-drone technologies — everything from laser cannons to heat-seeking missiles.

Drone Defense

The proliferation of cheap drones has given terrorists deadly new weapons, pranksters the tools to shut down major airports, and criminals the ability to scope out potential targets.

In response, according to a new story by the Wall Street Journal, weapon makers ranging from Boeing to Lockheed Martin are working on new anti-drone technologies — and they include laser cannons and heat-seeking missiles.

Gold Rush

Drones are deeply destabilizing because they’re relatively cheap, opening up strange new frontiers in security and warfare. According to the WSJ, experts estimate that anti-drone weapons will top an alarming $1.2 billion in sales next year — and $1.5 billion by 2021.

“Everyone is so preoccupied by this threat they are willing to give anything a try,” Arthur Holland Michel, the co-director of Bard College’s Center for the Study of the Drone, told the WSJ.

Buzz Off

Lockheed Martin is working on missiles to shoot down drones, according to the WSJ, and Boeing and a Chinese defense contractor are both developing laser cannons to blast them out of the sky.

A company in Singapore is working on a handheld gun that jams drones’ radio signals to take them down, the WSJ reports, and Diehl Defence is building a system that uses high-energy electronic bursts to frizzle up drones’ circuits from a distance.

Drones are “starting to become a really big problem,” Swedish defense company Saab AB executive Hakan Buskhe told the WSJ. Technology to remove drones from the sky “is something we are in discussion on with many countries and authorities around the globe.”

READ MORE: Weapon Makers Declare War on Drones [The Wall Street Journal]

More on drone warfare: The Maker of AK-47 Rifles Just Unveiled a “Suicide Drone”

The post Military Contractors Are Churning out New Anti-Drone Weapons appeared first on Futurism.

See original here:

Military Contractors Are Churning out New Anti-Drone Weapons

Thousands of Chinese Fans Paid to See a Virtual Hologram Singer

Hologram Performance

Thousands of fans convened at Shanghai’s Mercedes-Benz arena on Saturday to see an unusual show: a virtual hologram singer named Luo Tianyi, accompanied by world famous Chinese pianist Lang Lang.

But rather than basing the holographic performance on a particular human performer’s movement and voice — the way holograms of Michael Jackson and Tupac have “performed” on stage over the last decade — Tianyi’s performance is the result of six months of hard work by roughly 200 production staff, as the South China Morning Post (SCMP) reports.

Virtual Celebrity

Because she doesn’t exist as a real person, Tianyi is an intriguing vision of the future of entertainment.

Her voice and personality are created through sophisticated tech, including motion capture and 3D modelling. A backstage voice dubber and motion-capture actress even allowed Tianyi to interact with Lang Lang in real-time.

DIY Superstar

Luo isn’t the only virtual idol out there. In Japan — where the trend caught on first — Yamaha Vocaloid-based idols such as Hatsune Miku have turned the trend into a billion dollar market.

“Luo Tianyi is perfect,” Kit Cheung Jie, a 17-year-old senior high school student in Hong Kong told the South China Morning Post. “She is not a real person so she can be whatever you want her to be. It’s like a customized idol that only belongs to you.”

READ MORE: China’s virtual idols meet their fans at the intersection of entertainment and technology [SCMP]

More on holograms: Spinning Rods Create Stunning Holograms

The post Thousands of Chinese Fans Paid to See a Virtual Hologram Singer appeared first on Futurism.

More here:

Thousands of Chinese Fans Paid to See a Virtual Hologram Singer

Sperm Quality Is Falling. Chemicals in Your Home May Be to Blame.

The global sperm quality decline could be due in part to a pair of common household chemicals, according to a University of Nottingham study.

Sperm Fail

In the past 80 years, the quality of human sperm has declined by 50 percent — not only is sperm count down, but the sperm that do exist aren’t as mobile as their predecessors.

In 2016, a team of researchers from the University of Nottingham published a study noting that domestic dogs were experiencing a decline in sperm quality, too. This led them to wonder if something in the modern home environment might be contributing to the quality decline in both humans and dogs.

Based on a follow-up study, that guess appears to be correct — and the “something” at the center of it is human-made chemicals.

Double Damage

In a study published in the journal Scientific Reports on Monday, the University of Nottingham team details how it tested the impact of two human-made chemicals on the sperm of both humans and dogs.

One chemical, DEHP, is an additive that increases the plasticity of a material. It’s found in everything from carpet and upholstery to clothing and toys.

The other is polychlorinated biphenyl 153 (PCB153), an industrial chemical that once had a wide variety of applications. Though banned from production globally since 2001, PCB153 is still found in abundance in the environment — including in both human and dog food.

When the researchers incubated sperm from human and dog donors with concentrations of the chemicals comparable to those found in the natural environment, they found that the chemicals had the same damaging effect on both species’ sperm, decreasing its motility and increasing damage to its DNA.

In a news release, researcher Richard Lea said the findings “suggest that man-made chemicals that have been widely used in the home and working environment may be responsible for the fall in sperm quality reported in both man and dog that share the same environment.”

Man’s Best Friend

Not only is the study the first to find that DEHP and PCB153 impact sperm quality, but it also reveals that the impact is the same for humans and dogs, which could prove extremely valuable for future research on the global sperm quality decline — and the infertility crisis it’s causing.

“This means that dogs may be an effective model for future research into the effects of pollutants on declining fertility,” researcher Rebecca Sumner said in the news release, “particularly because external influences such as diet are more easily controlled than in humans.”

READ MORE: Chemical pollutants in the home degrade fertility in both men and dogs, study finds [University of Nottingham]

More on sperm quality: A Possible Culprit in the Infertility Crisis: Plastic

The post Sperm Quality Is Falling. Chemicals in Your Home May Be to Blame. appeared first on Futurism.

Read more from the original source:

Sperm Quality Is Falling. Chemicals in Your Home May Be to Blame.

Destroying Incoming Asteroids Might Be Harder Than We Thought

Based on a new computer model, asteroids are stronger than previously expected, meaning we'd have a tougher time destroying one headed for Earth.

Armageddon 2: The Asteroid Wins

It’s a very good thing an asteroid isn’t hurtling toward the Earth right now — because our current calculations on what it would take to destroy it might be way off.

“We used to believe that the larger the object, the more easily it would break, because bigger objects are more likely to have flaws,” Charles El Mir, one of the researchers behind a new Johns Hopkins University study on asteroid collisions, said in a press release. “Our findings, however, show that asteroids are stronger than we used to think and require more energy to be completely shattered.”

Crunched Numbers

The researchers detail how they reached that conclusion in a study set for publication in the March issue of the journal Icarus.

They started by creating a new computer model to simulate what would happen if an asteroid about one kilometer (.6 miles) in diameter slammed into another, with a diameter of 25 kilometers (15.5 miles), at a speed of five kilometers per second (3.1 miles per second).

Because the Johns Hopkins team’s model took into account more smaller-scale processes than previous simulations, it was able to provide what the researchers believe is a more accurate picture of what would happen during such a collision: rather than break apart entirely, as expected by previous models, the bigger asteroid would crack only partially.

Major Threat

According to researcher K.T. Ramesh, the team’s study reveals that we need to rethink what it would take to destroy an asteroid — before we actually have to destroy one.

“We are impacted fairly often by small asteroids, such as in the Chelyabinsk event a few years ago,” Ramesh said. “It is only a matter of time before these questions go from being academic to defining our response to a major threat. We need to have a good idea of what we should do when that time comes — and scientific efforts like this one are critical to help us make those decisions.”

READ MORE: Breaking up is hard to do: Asteroids are stronger, harder to destroy than previously thought [Johns Hopkins University]

More on asteroids: Retired Astronaut: NASA Left Earth Defenseless Against Asteroids

The post Destroying Incoming Asteroids Might Be Harder Than We Thought appeared first on Futurism.

Read this article:

Destroying Incoming Asteroids Might Be Harder Than We Thought

Stem Cell Therapy and Stem Cell Injection Provider Finder …

Stem cell therapy can be described as a means or process by which stem cells are used for the prevention, treatment or the cure of diseases. Stem cells are a special kind of cells that have features other types of cells dont have. As an illustration, stem cells are capable of proliferation. This implies that they can develop into any type of cell, and grow to start performing the functions of the tissue. In addition, they can regenerate. This means they can multiply themselves. This is most important when a new tissue has to be formed. Also, they modulate immune reactions. This has made them useful for the treatment of autoimmune diseases, especially those that affect the musculoskeletal system such as rheumatoid arthritis, systemic lupus erythematosus and so on. Stem cells can be derrived from different sources. They can be extracted from the body, and in some specific parts of the body. This includes the blood, bone marrow, umbilical cord in newborns, adipose tissue, and from embryos. There are 2 main types of stem cell transplant. These are autologous stem cell transplant, and allogeneic stem cell transplant. The autologous stem cell transplant means that stem cells are extracted from the patient, processed, and then transplanted back to the patient, for therapeutic purposes. On the other hand, allogeneic stem cell transplant means the transplant of stem cells or from another individual, known as the donor, to another person, or recipient. Some treatments must be given to the receiver to prevent any cases of rejections, and other complications. The autologous is usually the most preferred type of transplant because of its almost zero side effects. Below are some of the stem cell treatments. Our goal is to provide education, research and an opportunity to connect with Stem Cell Doctors, as well as provide stem cell reviews

Adipose Stem Cell TreatmentsAdipose stem cell treatment is one of the most commonly used. This is because large quantities of stem cells can be derrived from them. According to statistics, the number of stem cells in adipose tissue are usually hundreds of times higher than what can be obtained from other sources, such as the bone marrow stem cells. Adipose stem cells have taken the center stage in the world of stem cell therapy. Apart from the ease that comes with the harvesting of these cells from the adipose tissue, they also have some special features, that separates them from other types of cells. Adipose stem cells are capable of regulating and modulating the immune system. This includes immune suppression, which is important for the treatment of autoimmune diseases. In addition, adipose stem cells can differentiate to form other types of cells. Some of them include the bone forming cells, cardiomyocytes, and cells of the nervous system.

This process can be divided into four parts. These are

Stem cell joint injection is fast becoming the new treatment of joint diseases. Stem cells derived from bone marrow, adipose and mesenchymal stem cells are the most commonly used. The stem cells are injected into the joints, and they proceed to repair and replace the damaged tissues. The cells also modulate the inflammatory process going on. Overall, stem cell joint injections significantly reduce the recovery time of patients and also eliminates pain and risks associated with surgery. Examples of diseases where this treatment is used include osteoarthritis, rheumatoid arthritis, and so on. Researchers and physicians have rated this procedure to be the future of joint therapy.

Losing a tooth as a kid isnt news because youd eventually grow them back, but losing one as an adult isnt a pleasant experience. Youd have to go through the pains of getting a replacement from your dentist. Apart from the cost of these procedures, the pain and number of days youd have to stay at home nursing the pain is also a problem. Nevertheless, there are great teeth replacement therapies available for all kinds of dental problems. Although there are already good dental treatment methods, stem cell therapy might soon become the future of dental procedures. Currently, a lot of research is being done on how stem cells can be used to develop teeth naturally, especially in patients with dental problems. The aim of the project is to develop a method whereby peoples stem cells are used in regenerating their own teeth and within the shortest time possible. Some of the benefits of the stem cell tooth would be:

The quality of life of those that underwent serious procedures, especially those that had an allogeneic hematopoietic stem cell transplantation done was studied. It was discovered that this set of people had to cope with some psychological problems, even years after the procedure. In addition, allogeneic stem cell transplantation often comes with some side effects. However, this a small price to pay, considering that the adverse effects are not usually life-threatening. Also theses types of procedures are used for severe disorders or even terminal diseases. On the other hand, autologous stem cell transplantation bears the minimum to no side effects. Patients do have a great quality of life, both in the short term and in the long term.

This is one of the many uses of stem cells. The stem cell gun is a device that is used in treating people with wounds or burns. This is done by simply triggering it, and it sprays stem cells on the affected part. This kind of treatment is crucial for victims of a severe burn. Usually, people affected by severe burns would have to endure excruciating pain. The process of recovery is usually long, which might vary from weeks to months, depending on the severity of the burn. Even after treatment, most patients are left with scars forever. However, the stem cell gun eliminates these problems, the skin can be grown back in just a matter of days. The new skin also grows evenly and blends perfectly with the other part of the body. This process is also without the scars that are usually associated with the traditional burns therapy. The stem cell gun is without any side effects.

There is one company that focuses on the production of stem cell supplements. These stem cells are usually natural ingredients that increase the development of stem cells, and also keeps them healthy. The purpose of the stem cell supplements is to help reduce the aging process and make people look younger. These supplements work by replacing the dead or repairing the damaged tissues of the body. There have been a lot of testimonials to the efficacy of these supplements.

It is the goal of researchers to make stem cell therapy a good alternative for the millions of patients suffering from cardiac-related diseases. According to some experiments carried out in animals, stem cells were injected into the ones affected by heart diseases. A large percentage of them showed great improvement, even within just a few weeks. However, when the trial was carried out in humans, some stem cells went ahead to develop into heart muscles, but overall, the heart function was generally improved. The reason for the improvement has been attributed to the formation of new vessels in the heart. The topic that has generated a lot of arguments have been what type of cells should be used in the treatment of heart disorders. Stem cells extracted from the bone marrow, embryo have been in use, although bone marrow stem cells are the most commonly used. Stem cells extracted from bone marrow can differentiate into cardiac cells, while studies have shown that other stem cells cannot do the same. Even though the stem cell therapy has a lot of potential in the future, more research and studies have to be done to make that a reality.

The use of stem cells for the treatment of hair loss has increased significantly. This can be attributed to the discovery of stem cells in bone marrow, adipose cells, umbilical cord, and so on. Stem cells are extracted from the patient, through any of the sources listed above. Adipose tissue stem cells are usually the most convenient in this scenario, as they do not require any special extraction procedure. Adipose tissue is harvested from the abdominal area. The stem cells are then isolated from the other cells through a process known as centrifugation. The stem cells are then activated and are now ready for use. The isolated stem cells are then introduced into the scalp, under local anesthesia. The entire process takes about three hours. Patients are free to go home, after the procedure. Patients would begin to see improvements in just a few months, however, this depends largely on the patients ability to heal. Every patient has a different outcome.

Human umbilical stem cells are cells extracted from the umbilical cord of a healthy baby, shortly after birth. Umbilical cord tissue is abundant in stem cells, and the stem cells can differentiate into many types of cells such as red blood cells, white blood cells, and platelets. They are also capable of differentiating into non-blood cells such as muscle cells, cartilage cells and so on. These cells are usually preferred because its' extraction is minimally non invasive. It also is nearly painless. It also has zero risks of rejecting, as it does not require any form of matching or typing.Human umbilical stem cell injections are used for the treatment of spinal cord injuries. A trial was done on twenty-five patients that had late-stage spinal cord injuries. They were placed on human umbilical stem cell therapy, while another set of 25 patients were simultaneously placed on the usual rehabilitation therapy. The two groups were studied for the next twelve months. The results of the trial showed that those people placed on stem cell therapy by administering the human umbilical cell tissue injections had a significant recovery, as compared to the other group that underwent the traditional rehabilitation therapy. It was concluded that human umbilical tissue injections applied close to the injured part gives the best outcomes.

Stem cell therapy has been used for the treatment of many types diseases. This ranges from terminal illnesses such as cancer, joint diseases such as arthritis, and also autoimmune diseases. Stem cell therapy is often a better alternative to most traditional therapy today. This is because stem cell procedure is minimally invasive when compared to chemotherapy and so on. It harnesses the bodys own ability to heal. The stem cells are extracted from other parts of the body and then transplanted to other parts of the body, where they would repair and maintain the tissues. They also perform the function of modulating the immune system, which makes them important for the treatment of autoimmune diseases. Below are some of the diseases that stem cell therapies have been used successfully:

A stem cell bank can be described as a facility where stem cells are stored for future purposes. These are mostly amniotic stem cells, which are derived from the amnion fluid. Umbilical cord stem cells are also equally important as it is rich in stem cells and can be used for the treatment of many diseases. Examples of these diseases include cancer, blood disorders, autoimmune diseases, musculoskeletal diseases and so on. According to statistics, umbilical stem cells can be used for the treatment of over eighty diseases. Storing your stem cells should be seen as an investment in your health for future sake. Parents do have the option of either throwing away their babys umbilical cord or donating it to stem cell banks.

The adipose tissue contains a lot of stem cells, that has the ability to transform into other cells such as muscle, cartilage, neural cells. They are also important for the treatment of some cardiovascular diseases. This is what makes it important for people to want to store their stem cells. The future health benefit is huge. The only way adults can store their stem cells in sufficient amounts is to extract the stem cells from their fat tissues. This process is usually painless and fast. Although, the extraction might have to be done between 3 to 5 times before the needed quantity is gotten. People that missed the opportunity to store their stem cells, using their cord cells, can now store it using their own adipose tissues. This can be used at any point in time.

Side effects often accompany every kind of treatment. However, this depends largely on the individual. While patients might present with side effects, some other people wouldnt. Whether a patient will present with adverse effects, depends on the following factors;

Some of the common side effects of stem cell transplant are;

Stem cell treatment has been largely successful so far, however, more studies and research needs to be done. Stem cell therapy could be the future.

Stem cells are unique cells that have some special features such as self-regeneration, tissue repair, and modulation of the immune system. These are the features that are employed in the treatment of diseases.

Our doctors are certified by iSTEMCELL but operate as part of a medical group or as independent business owners and as such are free to charge what the feel to be the right fit for their practice and clients. We have seen Stem Cell Treatment costs range from $3500 upwards of $30,000 depending on the condition and protocol required for intended results. Find the Best Stem Cell Doctor Near me If you are interested in saving money, try our STEM CELL COUPON!

Travel Medcations are becoming very popular around the globe for several reasons but not for what one might think. It is not about traveling to Mexico to save money, but to get procedures or protocols that are not yet available in your home country. Many procedures are started in your home country, then the tissue is set to the tissue lab where it is then grown in a process to maximize live cells, then sent to a hospital in Mexico designed to treat or provide different therapies for different conditions. If you're ready to take a medical vacation call 972-800-6670 for our"WHITE GLOVE" service.

Chen, C. and Hou, J. (2016). Mesenchymal stem cell-based therapy in kidney transplantation. Stem Cell Research & Therapy, 7(1).

Donnelly, A., Johar, S., OBrien, T. and Tuan, R. (2010). Welcome to Stem Cell Research & Therapy. Stem Cell Research & Therapy, 1(1), p.1.

Groothuis, S. (2015). Changes in Stem Cell Research. Stem Cell Research, 14(1), p.130.

Rao, M. (2012). Stem cells and regenerative medicine. Stem Cell Research & Therapy, 3(4), p.27.

Vunjak-Novakovic, G. (2013). Physical influences on stem cells. Stem Cell Research & Therapy, 4(6), p.153.

View original post here:

Stem Cell Therapy and Stem Cell Injection Provider Finder ...

Stem cell – Wikipedia

Stem cells are cells that can differentiate into other types of cells, and can also divide in self-renewal to produce more of the same type of stem cells.

In mammals, there are two broad types of stem cells: embryonic stem cells, which are isolated from the inner cell mass of blastocysts, and adult stem cells, which are found in various tissues. In adult organisms, stem cells and progenitor cells act as a repair system for the body, replenishing adult tissues. In a developing embryo, stem cells can differentiate into all the specialized cellsectoderm, endoderm and mesoderm (see induced pluripotent stem cells)but also maintain the normal turnover of regenerative organs, such as blood, skin, or intestinal tissues.

There are three known accessible sources of autologous adult stem cells in humans:bone marrow, adipose tissue, and blood. Stem cells can also be taken from umbilical cord blood just after birth. Of all stem cell types, autologous harvesting involves the least risk. By definition, autologous cells are obtained from one's own body, just as one may bank his or her own blood for elective surgical procedures.

Adult stem cells are frequently used in various medical therapies (e.g., bone marrow transplantation). Stem cells can now be artificially grown and transformed (differentiated) into specialized cell types with characteristics consistent with cells of various tissues such as muscles or nerves. Embryonic cell lines and autologous embryonic stem cells generated through somatic cell nuclear transfer or dedifferentiation have also been proposed as promising candidates for future therapies.[1] Research into stem cells grew out of findings by Ernest A. McCulloch and James E. Till at the University of Toronto in the 1960s.[2][3]

The classical definition of a stem cell requires that it possesses two properties:

Two mechanisms exist to ensure that a stem cell population is maintained:

1. Obligatory asymmetric replication: a stem cell divides into one mother cell that is identical to the original stem cell, and another daughter cell that is differentiated.

When a stem cell self-renews it divides and does not disrupt the undifferentiated state. This self-renewal demands control of cell cycle as well as upkeep of multipotency or pluripotency, which all depends on the stem cell.[4]

2. Stochastic differentiation: when one stem cell develops into two differentiated daughter cells, another stem cell undergoes mitosis and produces two stem cells identical to the original.

Potency specifies the differentiation potential (the potential to differentiate into different cell types) of the stem cell.[5]

In practice, stem cells are identified by whether they can regenerate tissue. For example, the defining test for bone marrow or hematopoietic stem cells (HSCs) is the ability to transplant the cells and save an individual without HSCs. This demonstrates that the cells can produce new blood cells over a long term. It should also be possible to isolate stem cells from the transplanted individual, which can themselves be transplanted into another individual without HSCs, demonstrating that the stem cell was able to self-renew.

Properties of stem cells can be illustrated in vitro, using methods such as clonogenic assays, in which single cells are assessed for their ability to differentiate and self-renew.[8][9] Stem cells can also be isolated by their possession of a distinctive set of cell surface markers. However, in vitro culture conditions can alter the behavior of cells, making it unclear whether the cells shall behave in a similar manner in vivo. There is considerable debate as to whether some proposed adult cell populations are truly stem cells.[10]

Embryonic stem cells (ESCs) are the cells of the inner cell mass of a blastocyst, formed prior to implantation in the uterus.[11] In human embryonic development the blastocyst stage is reached 45 days after fertilization, at which time it consists of 50150 cells. ESCs are pluripotent and give rise during development to all derivatives of the three germ layers: ectoderm, endoderm and mesoderm. In other words, they can develop into each of the more than 200 cell types of the adult body when given sufficient and necessary stimulation for a specific cell type. They do not contribute to the extraembryonic membranes or to the placenta.

During embryonic development the cells of the inner cell mass continuously divide and become more specialized. For example, a portion of the ectoderm in the dorsal part of the embryo specializes as 'neurectoderm', which will become the future central nervous system.[12][pageneeded] Later in development, neurulation causes the neurectoderm to form the neural tube. At the neural tube stage, the anterior portion undergoes encephalization to generate or 'pattern' the basic form of the brain. At this stage of development, the principal cell type of the CNS is considered a neural stem cell.

The neural stem cells self-renew and at some point transition into radial glial progenitor cells. Early-formed RGPs self-renew by symmetrical division to form a reservoir group of progenitor cells. These cells transition to a neurogenic state and start to divide asymmetrically to produce a large diversity of many different neuron types, each with unique gene expression, morphological, and functional characteristics. The process of generating neurons from radial glial cells is called neurogenesis. The radial glial cell, has a distinctive bipolar morphology with highly elongated processes spanning the thickness of the neural tube wall. It shares some glial characteristics, most notably the expression of glial fibrillary acidic protein (GFAP).[13][14][15] The radial glial cell is the primary neural stem cell of the developing vertebrate CNS, and its cell body resides in the ventricular zone, adjacent to the developing ventricular system. Neural stem cells are committed to the neuronal lineages (neurons, astrocytes, and oligodendrocytes), and thus their potency is restricted.[12]

Nearly all research to date has made use of mouse embryonic stem cells (mES) or human embryonic stem cells (hES) derived from the early inner cell mass. Both have the essential stem cell characteristics, yet they require very different environments in order to maintain an undifferentiated state. Mouse ES cells are grown on a layer of gelatin as an extracellular matrix (for support) and require the presence of leukemia inhibitory factor (LIF) in serum media. A drug cocktail containing inhibitors to GSK3B and the MAPK/ERK pathway, called 2i, has also been shown to maintain pluripotency in stem cell culture.[16] Human ESCs are grown on a feeder layer of mouse embryonic fibroblasts and require the presence of basic fibroblast growth factor (bFGF or FGF-2).[17] Without optimal culture conditions or genetic manipulation,[18] embryonic stem cells will rapidly differentiate.

A human embryonic stem cell is also defined by the expression of several transcription factors and cell surface proteins. The transcription factors Oct-4, Nanog, and Sox2 form the core regulatory network that ensures the suppression of genes that lead to differentiation and the maintenance of pluripotency.[19] The cell surface antigens most commonly used to identify hES cells are the glycolipids stage specific embryonic antigen 3 and 4 and the keratan sulfate antigens Tra-1-60 and Tra-1-81. By using human embryonic stem cells to produce specialized cells like nerve cells or heart cells in the lab, scientists can gain access to adult human cells without taking tissue from patients. They can then study these specialized adult cells in detail to try and catch complications of diseases, or to study cells reactions to potentially new drugs. The molecular definition of a stem cell includes many more proteins and continues to be a topic of research.[20]

There are currently no approved treatments using embryonic stem cells. The first human trial was approved by the US Food and Drug Administration in January 2009.[21] However, the human trial was not initiated until October 13, 2010 in Atlanta for spinal cord injury research. On November 14, 2011 the company conducting the trial (Geron Corporation) announced that it will discontinue further development of its stem cell programs.[22] ES cells, being pluripotent cells, require specific signals for correct differentiationif injected directly into another body, ES cells will differentiate into many different types of cells, causing a teratoma. Differentiating ES cells into usable cells while avoiding transplant rejection are just a few of the hurdles that embryonic stem cell researchers still face.[23] Due to ethical considerations, many nations currently have moratoria or limitations on either human ES cell research or the production of new human ES cell lines. Because of their combined abilities of unlimited expansion and pluripotency, embryonic stem cells remain a theoretically potential source for regenerative medicine and tissue replacement after injury or disease.[24]

Human embryonic stem cell colony on mouse embryonic fibroblast feeder layer

The primitive stem cells located in the organs of fetuses are referred to as fetal stem cells.[25]There are two types of fetal stem cells:

Adult stem cells, also called somatic (from Greek , "of the body") stem cells, are stem cells which maintain and repair the tissue in which they are found.[27] They can be found in children, as well as adults.[28]

There are three known accessible sources of autologous adult stem cells in humans:

Stem cells can also be taken from umbilical cord blood just after birth. Of all stem cell types, autologous harvesting involves the least risk. By definition, autologous cells are obtained from one's own body, just as one may bank his or her own blood for elective surgical procedures.

Pluripotent adult stem cells are rare and generally small in number, but they can be found in umbilical cord blood and other tissues.[30] Bone marrow is a rich source of adult stem cells,[31] which have been used in treating several conditions including liver cirrhosis,[32] chronic limb ischemia [33] and endstage heart failure.[34] The quantity of bone marrow stem cells declines with age and is greater in males than females during reproductive years.[35] Much adult stem cell research to date has aimed to characterize their potency and self-renewal capabilities.[36] DNA damage accumulates with age in both stem cells and the cells that comprise the stem cell environment. This accumulation is considered to be responsible, at least in part, for increasing stem cell dysfunction with aging (see DNA damage theory of aging).[37]

Most adult stem cells are lineage-restricted (multipotent) and are generally referred to by their tissue origin (mesenchymal stem cell, adipose-derived stem cell, endothelial stem cell, dental pulp stem cell, etc.).[38][39] Muse cells (multi-lineage differentiating stress enduring cells) are a recently discovered pluripotent stem cell type found in multiple adult tissues, including adipose, dermal fibroblasts, and bone marrow. While rare, muse cells are identifiable by their expression of SSEA-3, a marker for undifferentiated stem cells, and general mesenchymal stem cells markers such as CD105. When subjected to single cell suspension culture, the cells will generate clusters that are similar to embryoid bodies in morphology as well as gene expression, including canonical pluripotency markers Oct4, Sox2, and Nanog.[40]

Adult stem cell treatments have been successfully used for many years to treat leukemia and related bone/blood cancers through bone marrow transplants.[41] Adult stem cells are also used in veterinary medicine to treat tendon and ligament injuries in horses.[42]

The use of adult stem cells in research and therapy is not as controversial as the use of embryonic stem cells, because the production of adult stem cells does not require the destruction of an embryo. Additionally, in instances where adult stem cells are obtained from the intended recipient (an autograft), the risk of rejection is essentially non-existent. Consequently, more US government funding is being provided for adult stem cell research.[43]

Multipotent stem cells are also found in amniotic fluid. These stem cells are very active, expand extensively without feeders and are not tumorigenic. Amniotic stem cells are multipotent and can differentiate in cells of adipogenic, osteogenic, myogenic, endothelial, hepatic and also neuronal lines.[44]Amniotic stem cells are a topic of active research.

Use of stem cells from amniotic fluid overcomes the ethical objections to using human embryos as a source of cells. Roman Catholic teaching forbids the use of embryonic stem cells in experimentation; accordingly, the Vatican newspaper "Osservatore Romano" called amniotic stem cells "the future of medicine".[45]

It is possible to collect amniotic stem cells for donors or for autologuous use: the first US amniotic stem cells bank [46][47] was opened in 2009 in Medford, MA, by Biocell Center Corporation[48][49][50] and collaborates with various hospitals and universities all over the world.[51]

Adult stem cells have limitations with their potency; unlike embryonic stem cells (ESCs), they are not able to differentiate into cells from all three germ layers. As such, they are deemed multipotent.

However, reprogramming allows for the creation of pluripotent cells, induced pluripotent stem cells (iPSCs), from adult cells. These are not adult stem cells, but adult cells (e.g. epithelial cells) reprogrammed to give rise to cells with pluripotent capabilities. Using genetic reprogramming with protein transcription factors, pluripotent stem cells with ESC-like capabilities have been derived.[52][53][54] The first demonstration of induced pluripotent stem cells was conducted by Shinya Yamanaka and his colleagues at Kyoto University.[55] They used the transcription factors Oct3/4, Sox2, c-Myc, and Klf4 to reprogram mouse fibroblast cells into pluripotent cells.[52][56] Subsequent work used these factors to induce pluripotency in human fibroblast cells.[57] Junying Yu, James Thomson, and their colleagues at the University of WisconsinMadison used a different set of factors, Oct4, Sox2, Nanog and Lin28, and carried out their experiments using cells from human foreskin.[52][58] However, they were able to replicate Yamanaka's finding that inducing pluripotency in human cells was possible.

Induced pluripotent stem cells differ from embryonic stem cells. They share many similar properties, such as pluripotency and differentiation potential, the expression of pluripotency genes, epigenetic patterns, embryoid body and teratoma formation, and viable chimera formation,[55][56] but there are many differences within these properties. The chromatin of iPSCs appears to be more "closed" or methylated than that of ESCs.[55][56] Similarly, the gene expression pattern between ESCs and iPSCs, or even iPSCs sourced from different origins.[55] There are thus questions about the "completeness" of reprogramming and the somatic memory of induced pluripotent stem cells. Despite this, inducing adult cells to be pluripotent appears to be viable.

As a result of the success of these experiments, Ian Wilmut, who helped create the first cloned animal Dolly the Sheep, has announced that he will abandon somatic cell nuclear transfer as an avenue of research.[59]

Furthermore, induced pluripotent stem cells provide several therapeutic advantages. Like ESCs, they are pluripotent. They thus have great differentiation potential; theoretically, they could produce any cell within the human body (if reprogramming to pluripotency was "complete").[55] Moreover, unlike ESCs, they potentially could allow doctors to create a pluripotent stem cell line for each individual patient.[60] Frozen blood samples can be used as a valuable source of induced pluripotent stem cells.[61] Patient specific stem cells allow for the screening for side effects before drug treatment, as well as the reduced risk of transplantation rejection.[60] Despite their current limited use therapeutically, iPSCs hold create potential for future use in medical treatment and research.

To ensure self-renewal, stem cells undergo two types of cell division (see Stem cell division and differentiation diagram). Symmetric division gives rise to two identical daughter cells both endowed with stem cell properties. Asymmetric division, on the other hand, produces only one stem cell and a progenitor cell with limited self-renewal potential. Progenitors can go through several rounds of cell division before terminally differentiating into a mature cell. It is possible that the molecular distinction between symmetric and asymmetric divisions lies in differential segregation of cell membrane proteins (such as receptors) between the daughter cells.[62]

An alternative theory is that stem cells remain undifferentiated due to environmental cues in their particular niche. Stem cells differentiate when they leave that niche or no longer receive those signals. Studies in Drosophila germarium have identified the signals decapentaplegic and adherens junctions that prevent germarium stem cells from differentiating.[63][64]

Stem cell therapy is the use of stem cells to treat or prevent a disease or condition. Bone marrow transplant is a form of stem cell therapy that has been used for many years without controversy.[65][66]

Stem cell treatments may lower symptoms of the disease or condition that is being treated. The lowering of symptoms may allow patients to reduce the drug intake of the disease or condition. Stem cell treatment may also provide knowledge for society to further stem cell understanding and future treatments.[67]

Stem cell treatments may require immunosuppression because of a requirement for radiation before the transplant to remove the person's previous cells, or because the patient's immune system may target the stem cells. One approach to avoid the second possibility is to use stem cells from the same patient who is being treated.

Pluripotency in certain stem cells could also make it difficult to obtain a specific cell type. It is also difficult to obtain the exact cell type needed, because not all cells in a population differentiate uniformly. Undifferentiated cells can create tissues other than desired types.[68]

Some stem cells form tumors after transplantation;[69] pluripotency is linked to tumor formation especially in embryonic stem cells, fetal proper stem cells, induced pluripotent stem cells. Fetal proper stem cells form tumors despite multipotency.[70]

Some of the fundamental patents covering human embryonic stem cells are owned by the Wisconsin Alumni Research Foundation (WARF) they are patents 5,843,780, 6,200,806, and 7,029,913 invented by James A. Thomson. WARF does not enforce these patents against academic scientists, but does enforce them against companies.[71]

In 2006, a request for the US Patent and Trademark Office (USPTO) to re-examine the three patents was filed by the Public Patent Foundation on behalf of its client, the non-profit patent-watchdog group Consumer Watchdog (formerly the Foundation for Taxpayer and Consumer Rights).[71] In the re-examination process, which involves several rounds of discussion between the USPTO and the parties, the USPTO initially agreed with Consumer Watchdog and rejected all the claims in all three patents,[72] however in response, WARF amended the claims of all three patents to make them more narrow, and in 2008 the USPTO found the amended claims in all three patents to be patentable. The decision on one of the patents (7,029,913) was appealable, while the decisions on the other two were not.[73][74] Consumer Watchdog appealed the granting of the '913 patent to the USPTO's Board of Patent Appeals and Interferences (BPAI) which granted the appeal, and in 2010 the BPAI decided that the amended claims of the '913 patent were not patentable.[75] However, WARF was able to re-open prosecution of the case and did so, amending the claims of the '913 patent again to make them more narrow, and in January 2013 the amended claims were allowed.[76]

In July 2013, Consumer Watchdog announced that it would appeal the decision to allow the claims of the '913 patent to the US Court of Appeals for the Federal Circuit (CAFC), the federal appeals court that hears patent cases.[77] At a hearing in December 2013, the CAFC raised the question of whether Consumer Watchdog had legal standing to appeal; the case could not proceed until that issue was resolved.[78]

Diseases and conditions where stem cell treatment is being investigated include:

Research is underway to develop various sources for stem cells, and to apply stem cell treatments for neurodegenerative diseases and conditions, diabetes, heart disease, and other conditions.[94] Research is also underway in generating organoids using stem cells, which would allow for further understanding of human development, organogenesis, and modeling of human diseases.[95]

In more recent years, with the ability of scientists to isolate and culture embryonic stem cells, and with scientists' growing ability to create stem cells using somatic cell nuclear transfer and techniques to create induced pluripotent stem cells, controversy has crept in, both related to abortion politics and to human cloning.

Hepatotoxicity and drug-induced liver injury account for a substantial number of failures of new drugs in development and market withdrawal, highlighting the need for screening assays such as stem cell-derived hepatocyte-like cells, that are capable of detecting toxicity early in the drug development process.[96]

See the original post:

Stem cell - Wikipedia

Stem Cell Treatment/Therapy COST in India| DheerajBojwani.Com

Get your Stem Cell Treatment in India with Dheeraj Bojwani Consultants

Stem Cell treatment is an intricate process. Stem Cell transplant patients need utmost care with respect to both emotionally and physically. Dheeraj Bojwani Consultants is a prominent medical tourism company in India making world-class medical facilities from best surgeons and hospitals accessible for international patients looking for budget-friendly treatment abroad.

Mrs. Marilyn Obiora - Nigeria Stem Cell Therapy For her Daughter in India

Hi, my name is Mrs. Marilyn Obiora, and I am from Nigeria. I came to India for my daughter's Stem Cell Therapy in India. My daughter had her first stroke in 2011. She couldn't sit, talk and had lost control of her neck. We could not find suitable help for her condition and searched for treatment in India.

We sent a query to the dheerajbojwani.com and received fast reply. Within no time we were in India for my daughter's treatment. We are very pleased with the treatment offered and there has been serious improvement in her condition in just two weeks. Thanks to the Dheeraj Bojwani Consultants, my daughter is regaining proper body functions and recuperating well.

Medical science has come a long way since its practice began thousands of years ago. Scientists are finding superior and more resourceful ways to cure diseases of different organs. Stem cells are undifferentiated parent cells that can transform into specialized cell types, divide further and produce more stem cells of the same group. Stem Cell therapy is performed to prevent or treat a health condition. Stem Cell Treatment is a reproductive therapy where nourishing tissues reinstate damaged tissues for relief from incurable diseases. Stem cell treatment is one of the approaches with a potential to heal a wide range of diseases in the near future. Science has always provided ground-breaking answers to obdurate health conditions, but the latest medical miracle that the medical fraternity has gifted to mankind is the Stem Cell Therapy.

Stem cell therapy is an array of techniques intended to replace cells damaged or destroyed by disease with healthy functioning ones. Even though the techniques are relatively new, their applications and advantages are broad and surprising the medical world with every new research. Stem cells are obtained from bone marrow or human umbilical cord. They are also known as the fundamental cells of our body and have the power to develop into any type of tissue cell in the body. Stem cell treatment is based on the principle that the cells move to the site of injury and transform themselves to form new tissue cells to replace the damaged ones. They have the capacity to proliferate and renew themselves indefinitely and can form mature muscle cells, nerve cells, and blood cells. In this type of therapy, they are derived from the body, kept under artificial conditions where they mature into the type of cells that are required to heal a certain part of the body or disease.

Stem cells are being studied and used to treat different types of cancers, disorders related to the blood, immune disorders, and metabolic disorders. Some other diseases and health conditions that may be healed using stem cell treatment are,

Recently, a team of researchers successfully secured the peripheral nerves in the upper arms of a patient suffering peripheral nerve damage, by using skin-derived stem cells (SDSCs) and a previously developed collagen tube, premeditated to successfully bridge gaps in injured nerves.

A research has found potential in bone marrow stem cell therapy to treat TB. Patients injected with new mesenchymal stromal cells derived from their own bone marrow showed positive response against the TB bacteria. The therapy also didnt show any serious adverse effects.

Stem cells are also used to treat hair loss. A small amount of fat is taken from the waist area of the patient by a mini-liposuction process. This fat contains dormant stem cells, and is then spun to separate the stem cells from the fat. An activation solution is added to the cells, and may be multiplied in number, depending on the size of the bald area. Once activated, the solution is washed off so that only cells remain. Now, the stem cells are injected into the scalp. One can find some hair growth in about two to four weeks.

Damaged cones in retinas can be regenerated and eyesight restored through stem cell. Stem cell therapy could regenerate damaged cones in people, especially in the cone-rich regions of the retina that provide daytime/color vision.

Kidney transplants have become more common and easier thanks stem cell therapy. Normally patients who undergo organ transplants need a lifetime of costly anti-rejection drugs but the new procedure may negate this need, with organ donors stem cells. Unless there is a perfect match donor, patients have to wait long for an organ transplant. Though still in early stages, the stem cell research is being considered as a potential player in the field of transplantation.

Transplanted stem cells serve as migratory signals for the brain's own neurogenic cells, guiding the new host cells towards the injured brain tissue. Stem cells have the potential to give rise to many different cell types that carry out different functions. While the stem cells in adult bone marrow tend to develop into the cells that make up the organ system from which they originated. These multipotent stem cells can be manipulated to take up the characteristics of neural cells.

Experts are using Stem cell Transplant to treat the symptoms of spinal cord injury by transplantation of cells directly into the gray matter of the patients spinal cord. Expectedly, the cells will integrate into the patients own neural tissue and create new circuitry to help transmit nerve signals to muscles. The transplanted cells may also promote reorganization of the spinal cord segmental circuitry, possibly leading to improved motor function.

Stem cells are capable of differentiating into a variety of different cell types, and if the architecture of damaged tendon is restored, it would improve the management of patients with these injuries significantly.

A promising benefit of stem cell therapy is its potential for cardiac tissue regeneration to reverse tissue loss underlying the development of heart failure after cardiac injury. Possible mechanisms of recovery include generation of heart muscle cells, stimulation of new blood vessels growth, secretion of growth factors.

It is a complex and multifarious procedure, with several risks and complications involved and is thus recommended to a few patients when other treatments have failed. Stem Cell therapy is recommended when other treatments fail to give positive results. The best candidates for Stem cell Treatment are those in good health and have stem cells available from a sibling, or any other family member.

India has been recognized as the new medical destination for Stem Cell therapies. Hundreds of international patients from around the world visit to India for high quality medical care at par with developed nations like the US, UK, at the most affordable costs.

The Hospitals in India have the most extensive diagnostic and imaging facilities including Asias most advanced MRI and CT technology. India provides services of the most leading doctors and Stem Cell Therapy professionals at reasonable cost budget in the following cities :

Ms. Olu Adegbenro from Nigeria

Thanks to Dheeraj Bojwani Group for today I can live a happy life. Three years ago, I was diagnosed with optical atrophy due to advanced staged of Glaucoma. Eventually it turned up to as stage where my vision was completely impaired. Then, when I connected with the Dheeraj Bojwani Group after lots of research, evaluation, judgments and discussion, a specialist from the group suggested stem cell therapy. Today its been five years after the Therapy and I am extremely happy with the results of my stem cell treatment in India as my vision has improved a lot post treatment.

India offers outstanding Stem Cell Treatment at cost far below that prevailing in USA or other Western countries. Even with travel expenses taken into account, the comprehensive medical tourism packages still provide a savings measured in the thousands of dollars for major procedures. A cost comparison can give you the exact idea about the difference which shows the low cost stem cell treatment in India :

There are many reasons for India becoming a popular medical tourism spot is the low cost stem cell treatment in the area. When in contrast to the first world countries like, US and UK, medical care in India costs as much as 60-90% lesser, that makes it a great option for the citizens of those countries to opt for stem cell treatment in India because of availability of top stem cell treatment clinics in India, affordable prices strategic connectivity, food, zero language barrier and many other reasons.

The maximum number of patients for Stem Cell Treatment comes from Nigeria, Kenya, Ethiopia, USA, UK, Australia, Saudi Arabia, UAE, Uzbekistan, Bangladesh

Below are the downloadable links that will help you to plan your medical trip to India in a more organized and better way. Attached word and pdf files gives information that will help you to know India more and make your trip to India easy and memorable one.

Back

Read more from the original source:

Stem Cell Treatment/Therapy COST in India| DheerajBojwani.Com

Stem Cell Therapy in India, Low Cost Stem Cell Therapy in …

Plan your Stem Cell Therapy in India with Tour2India4Health Consultants

Stem cell therapy in India is performed by highly skilled and qualified doctors and surgeons in India. Our hospitals have state-of-art equipment that increase success rate of stem cell therapy in India. Tour2India4Health is a medical value provider that offers access to the stem cell therapy for patients from any corner of the world. We offer low cost stem cell therapy at the best hospitals in India.

Stem cells are cells that have the potential to develop into some or many different cell types in the body, depending on whether they are multipotent or pluripotent. Serving as a sort of repair system, they can theoretically divide without limit to replenish other cells for as long as the person or animal is still alive. When a stem cell divides, each "daughter" cell has the potential to either remain a stem cell or become another type of cell with a more specialized function, such as a muscle cell, a red blood cell, or a brain cell.

There are three classes of stem cells i.e totipotent, pluripotent and multipotent (also known as unipotent).

Many different terms are used to describe various types of stem cells, often based on where in the body or what stage in development they come from. You may have heard the following terms:

Adult Stem Cells or Tissue-specific Stem Cells: Adult stem cells are tissue-specific, meaning they are found in a given tissue in our bodies and generate the mature cell types within that particular tissue or organ. It is not clear whether all organs, such as the heart, contain stem cells. The term adult stem cells is often used very broadly and may include fetal and cord blood stem cells.

Fetal Stem Cells: As their name suggests, fetal stem cells are taken from the fetus. The developing baby is referred to as a fetus from approximately 10 weeks of gestation. Most tissues in a fetus contain stem cells that drive the rapid growth and development of the organs. Like adult stem cells, fetal stem cells are generally tissue-specific, and generate the mature cell types within the particular tissue or organ in which they are found.

Cord Blood Stem Cells: At birth the blood in the umbilical cord is rich in blood-forming stem cells. The applications of cord blood are similar to those of adult bone marrow and are currently used to treat diseases and conditions of the blood or to restore the blood system after treatment for specific cancers. Like the stem cells in adult bone marrow, cord blood stem cells are tissue-specific.

Embryonic Stem Cells: Embryonic stem cells are derived from very early embryos and can in theory give rise to all cell types in the body. While these cells are already helping us better understand diseases and hold enormous promise for future therapies, there are currently no treatments using embryonic stem cells accepted by the medical community.

Induced Pluripotent Stem Cells (IPS cells): In 2006, scientists discovered how to reprogram cells with a specialized function (for example, skin cells) in the laboratory, so that they behave like an embryonic stem cell. These cells, called induced pluripotent cells or IPS cells, are created by inducing the specialized cells to express genes that are normally made in embryonic stem cells and that control how the cell functions.

Embryonic stem cells are derived from the inner cell mass of a blastocyst: the fertilized egg, called the zygote, divides and forms two cells; each of these cells divides again, and so on. Soon there is a hollow ball of about 150 cells called the blastocyst that contains two types of cells, the trophoblast and the inner cell mass. Embryonic stem cells are obtained from the inner cell mass.

Stem cells can also be found in small numbers in various tissues in the fetal and adult body. For example, blood stem cells are found in the bone marrow that give rise to all specialized blood cell types. Such tissue-specific stem cells have not yet been identified in all vital organs, and in some tissues like the brain, although stem cells exist, they are not very active, and thus do not readily respond to cell injury or damage.

Stem cells can also be obtained from other sources, for example, the umbilical cord of a newborn baby is a source of blood stem cells. Recently, scientists have also discovered the existence of cells in baby teeth and in amniotic fluid that may also have the potential to form multiple cell types. Research on these cells is at a very early stage.

Stem cell therapy is the use of stem cells to treat certain diseases. Stem cells are obtained from the patients own blood bone marrow, fat and umbilical cord tissue or blood. They are progenitor cells that lead to creation of new cells and are thus called as generative cells as well.

The biological task of stem cells is to repair and regenerate damaged cells. Stem cell therapy exploits this function by administering these cells systematically and in high concentrations directly into the damaged tissue, where they advance its self-healing. The process that lies behind this mechanism is largely unknown, but it is assumed that stem cells discharge certain substances which activate the diseased tissue. It is also conceivable that single damaged somatic cells, e.g. single neurocytes in the spinal cord or endothelium cells in vessels, are replaced by stem cells. Most scientists agree that stem cell research has great life-saving potential and could revolutionize the study and treatment of diseases and injuries.

Stem cell therapy is useful in certain degenerative diseases like

If stem cell therapy is an option, a detailed treatment plan is prepared depending on the type of treatment necessary. Once the patient has consented to the treatment plan, an appointment is scheduled for bone marrow extraction. Please note that this is a minimally invasive surgical procedure, so it is important that patients do not take any blood-thinning medication in the ten days prior to the appointment. It is necessary for each patient to consult their own doctor before discontinuing this type of medication.

The treatment procedure include:

Bone Marrow Extraction: Bone marrow is extracted from the hip bone by the physicians. This procedure normally takes around 30 minutes. First, local anesthetic is administered to the area of skin where the puncture will be made. Then, a thin needle is used to extract around 150-200 ml of bone marrow. The injection of local anesthetic can be slightly painful, but the patient usually does not feel the extraction of bone marrow.

Isolation, Analysis and Concentration of the Stem Cells in the Laboratory: The quality and quantity of the stem cells contained in the collected bone marrow are tested at the laboratory. First, the stem cells are isolated. Then a chromatographical procedure is used to separate them from the red and white blood corpuscles and plasma. The sample is tested under sterile conditions so that the stem cells, which will be administered to the patient, are not contaminated with viruses, bacteria or fungi. Each sample is also tested for the presence of viral markers such as HIV, hepatitis B and C and cytomegalia. The cleaned stem cells are counted and viability checks are made. If there are enough viable stem cells, i.e. more than two million CD34+ cells with over 80 percent viability, the stem cell concentrate is approved for patient administration.

Stem Cell Implantation: The method of stem cell implantation depends on the patient's condition. There are four different ways of administering stem cells:

Intravenous administration:

It is important to understand that while stem cell therapy can help alleviate symptoms in many patients and slow or even reverse degenerative processes, it does not work in all cases. Based on additional information, patient's current health situation and/or unforeseen health risks, the medical staff can always, in the interest of the individual patient, propose another kind of stem cell transplantation or in exceptional situations cancel the treatment.

The side effects of stem cell therapy differ from person to person. Listed below are the side effects of stem cell therapy :

According to the Indian Council of Medical Research, all is considered to be experimental, with the exception of bone marrow transplants. However, the guidelines that were put into place in 2007 are largely non-enforceable. Regardless, stem cell therapy is legalized in India. Umbilical cord and adult stem cell treatment are considered permissible. Embryonic stem cell therapy and research is restricted.

There is about a 60% to 80% overall success rate in the use of stem cell therapy in both India and around the world. However, success rates vary depending on the disease being treated, the institute conducting the procedures, and the condition of the patient. In order to receive complete information you will have to contact the medical institutes and ask specific questions concerning the patient's condition.

Mrs. Selina Naidoo with her Son from Malaysia

Tour2India4Health has proved to be a blessing in disguise for me. A medical tourism company with everything at par with our expectations has given me the most satisfactory and relieving experience of my life. I went to them for my sons surgery who was suffering from a serious illness and stem cell therapy was the only choice I had. Trust it was heart wrenching to leave my son under any hands on the operation table. Nevertheless, courageously I had to because thats what I was here for and thats what could get my son a new and healthy life. Sitting at a corner outside the operation theatre was taking my heartbeats away with every second. Finally, the surgery was over and I was there in front of the doctor with closed eyes. He declared that the surgery was successful and my son is fine but needs some extra care and some cautious post operative measures for recovery. All through our stay in the hospital, everything went on brilliantly and after my son recovered completely, I came back to my home country. Even after that for many months, I received regular calls to verify and virtually monitor the health of my child. Now, its been 5 years and when I see my child today it feels as if no surgery was ever done on him. Thanks to the doctor who treated him and to the entire team of nurses and travel professionals who displayed extra warmth and care. Thanks is just a small word to say as a mother of a child.

India is the most preferable destination for patients who are looking for low cost stem cell therapy. Indian doctors and healthcare professionals are renowned world over for their skills with many of them holding high positions in leading hospitals in US, UK and other countries around the world. There are significant numbers of highly skilled experts in India, including many who have relocated to India after having worked in the top hospitals across the world.

Stem Cell Therapy costs in India are generally about a tenth of the costs in US and are significantly cheaper compared with even other medical travel destinations like Thailand

*The price for the Stem Cell Therapy is an average collected from the 15 best corporate hospitals and 10 Top Stem Cell Experts of India.

*The final prices offered to the patients is based on their medical reports and is dependent on the current medical condition of the patient, type of room, type of therapy, hospital brand and the surgeon's expertise.

We have worked out special packages of the Stem Cell Therapy for our Indian and International patients. You can send us your medical reports to avail the benefits of these special packages.

You would be provided with 3 TOP RECOMMENDED SURGEONS / HOSPITALS FOR YOUR STEM CELL THERAPY in India.

There are many reasons for India becoming a popular medical tourism spot is the low cost stem cell treatment in the area. When in contrast to the first world countries like, US and UK, medical care in India costs as much as 60-90% lesser, that makes it a great option for the citizens of those countries to opt for stem cell treatment in India because of availability of quality healthcare in India, affordable prices strategic connectivity, food, zero language barrier and many other reasons.

The maximum number of patients for stem cell therapy comes from Nigeria, Kenya, Ethiopia, USA, UK, Australia, Saudi Arabia, UAE, Uzbekistan, Bangladesh.

Cities where top and world renowned Stem Cell Therapy hospitals and clinics situated are :

We have PAN-India level tie ups with TOP Hospitals for Stem Cell Therapy across 15+ major cities in India. We can provide you with multiple top hospitals & best surgeons recommendations for Stem Cell Therapy in India.

India has now been recognized as one of the leaders in medical field of research and treatment. Tour2India4Health Group was established with an aim of providing best medical services to its patients and since then has been working hard in maintaining itself as one of the most professional healthcare tourism providers in India. With a number of world-renowned medical facilities affiliated, we have the resources to offer you the finest medical treatment in India, and help your speedy recovery. Tour2India4Health Group has always believed and practiced providing its patients best surgery and treatment procedure giving a second chance to live a more better and normal life. Our team serves the clientele most comfortable and convenient measures of healthcare services thus, making your medical tour to India very fruitful experience.

Our facilitation:

We has been operating patients from all major countries like USA, United Kingdom, Italy, Australia, Canada, Spain, New Zealand, and Kuwait etc. We have network of selected medical centers, surgeons and physicians around various cities in India, who qualify our assessment criteria to ensure that our core values of Safety, Excellence and Trust are maintained in all our services.

Below are the downloadable links that will help you to plan your medical trip to India in a more organized and better way. Attached word and pdf files gives information that will help you to know India more and make your trip to India easy and memorable one.

Stem Cell Therapy in India, Low Cost Stem Cell Therapy in India, Stem Cell Therapy Benefits India, stem cell therapy experience in india

See the original post:

Stem Cell Therapy in India, Low Cost Stem Cell Therapy in ...

Ripple Price Forecast: XRP vs SWIFT, SEC Updates, and More

Ripple vs SWIFT: The War Begins
While most criticisms of XRP do nothing to curb my bullish Ripple price forecast, there is one obstacle that nags at my conscience. Its name is SWIFT.

The Society for Worldwide Interbank Financial Telecommunication (SWIFT) is the king of international payments.

It coordinates wire transfers across 11,000 banks in more than 200 countries and territories, meaning that in order for XRP prices to ascend to $10.00, Ripple needs to launch a successful coup. That is, and always has been, an unwritten part of Ripple’s story.

We’ve seen a lot of progress on that score. In the last three years, Ripple wooed more than 100 financial firms onto its.

The post Ripple Price Forecast: XRP vs SWIFT, SEC Updates, and More appeared first on Profit Confidential.

Excerpt from:

Ripple Price Forecast: XRP vs SWIFT, SEC Updates, and More

Cryptocurrency Price Forecast: Trust Is Growing, But Prices Are Falling

Trust Is Growing...
Before we get to this week’s cryptocurrency news, analysis, and our cryptocurrency price forecast, I want to share an experience from this past week. I was at home watching the NBA playoffs, trying to ignore the commercials, when a strange advertisement caught my eye.

It followed a tomato from its birth on the vine to its end on the dinner table (where it was served as a bolognese sauce), and a diamond from its dusty beginnings to when it sparkled atop an engagement ring.

The voiceover said: “This is a shipment passed 200 times, transparently tracked from port to port. This is the IBM blockchain.”

Let that sink in—IBM.

The post Cryptocurrency Price Forecast: Trust Is Growing, But Prices Are Falling appeared first on Profit Confidential.

Read the original:

Cryptocurrency Price Forecast: Trust Is Growing, But Prices Are Falling

Cryptocurrency News: Bitcoin ETF Rejection, AMD Microchip Sales, and Hedge Funds

Cryptocurrency News
Although cryptocurrency prices were heating up last week (Bitcoin, especially), regulators poured cold water on the rally by rejecting calls for a Bitcoin exchange-traded fund (ETF). This is the second time that the proposal fell on deaf ears. (More on that below.)

Crypto mining ran into similar trouble, as you can see from Advanced Micro Devices, Inc.'s (NASDAQ:AMD) most recent quarterly earnings. However, it wasn't all bad news. Investors should, for instance, be cheering the fact that hedge funds are ramping up their involvement in cryptocurrency markets.

Without further ado, here are those stories in greater detail.
ETF Rejection.

The post Cryptocurrency News: Bitcoin ETF Rejection, AMD Microchip Sales, and Hedge Funds appeared first on Profit Confidential.

Link:

Cryptocurrency News: Bitcoin ETF Rejection, AMD Microchip Sales, and Hedge Funds

Cryptocurrency News: What You Need to Know This Week

Cryptocurrency News
Cryptocurrencies traded sideways since our last report on cryptos. However, I noticed something interesting when playing around with Yahoo! Finance’s cryptocurrency screener: There are profitable pockets in this market.

Incidentally, Yahoo’s screener is far superior to the one on CoinMarketCap, so if you’re looking to compare digital assets, I highly recommend it.

But let's get back to my epiphany.

In the last month, at one point or another, most crypto assets on our favorites list saw double-digit increases. It’s true that each upswing was followed by a hard crash, but investors who rode the trend would have made a.

The post Cryptocurrency News: What You Need to Know This Week appeared first on Profit Confidential.

Originally posted here:

Cryptocurrency News: What You Need to Know This Week

Cryptocurrency News: XRP Validators, Malta, and Practical Tokens

Cryptocurrency News & Market Summary
Investors finally saw some light at the end of the tunnel last week, with cryptos soaring across the board. No one quite knows what kicked off the rally—as it could have been any of the stories we discuss below—but the net result was positive.

Of course, prices won’t stay on this rocket ride forever. I expect to see a resurgence of volatility in short order, because the market is moving as a single unit. Everything is rising in tandem.

This tells me that investors are simply “buying the dip” rather than identifying which cryptos have enough real-world value to outlive the crash.

So if you want to know when.

The post Cryptocurrency News: XRP Validators, Malta, and Practical Tokens appeared first on Profit Confidential.

Read the original post:

Cryptocurrency News: XRP Validators, Malta, and Practical Tokens


...1020...2829303132...405060...